glp-1 causing migraines Drug Cuts Migraine Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity and chronic migraine. Participants reported an average Migraines & Ozempic: Biomarker Context

Planta Med

Research shows that GLP-1 medications do not directly bind to or metabolize lamotrigine, so there is no chemical interaction at the liver or kidney level

Different combinations or even larger cocktails of agonists and/or antagonists may turn out to be even more effective going forward

The BioJet systemic oral delivery platform (previously called the Oral Biotherapeutic Delivery system, or OBDS) is an ingestible drug-device combination developed to prevent drug degradation in the upper gastrointestinal tract and increase drug bioavailability via needleless jet injection in the proximal small intestine following oral administration